{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"11"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"50"}],"units":"Participants"}],"groups":[{"description":"* Two 8 oz. bottles of Enterade will be administered daily\n* Enterade will be given orally from admission until day +14 or until discharge\n* Standard Supportive Care will be administered according to institution's practice\n\nEnterade\n\nStandard Supportive Care","id":"OG000","title":"Enterade and Standard Supportive Care"},{"description":"* Two 8 oz. bottles of Placebo will be administered daily\n* Placebo will be given orally from admission until day +14 or until discharge\n* Standard Supportive Care will be administered according to institution's practice\n\nPlacebo\n\nStandard Supportive Care","id":"OG001","title":"Placebo and Standard Supportive Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Patients who take the study drug two 8 oz. bottles (480 ml) daily for at least 11 days are regarded as compliant. Compliance is assessed among patients who received any amount of the study drug (N=99).Only 17 participants met the protocol definition of compliance","reportingStatus":"POSTED","timeFrame":"14 days","title":"the Tolerability of Enterade® as Measured by the Number of Compliant Patients","type":"SECONDARY","unitOfMeasure":"Participants"}